White Rose University Consortium logo
University of Leeds logo University of Sheffield logo York University logo

The Effect of Antiplatelet Medications on Innate Immune Activation

Thomas, Mark (2015) The Effect of Antiplatelet Medications on Innate Immune Activation. PhD thesis, University of Sheffield.

Text (PhD Thesis)
Thesis Revised Final.pdf
Available under License Creative Commons Attribution-Noncommercial-No Derivative Works 2.0 UK: England & Wales.

Download (34Mb) | Preview


Objective - Clinical studies suggest that platelet P2Y12 inhibitors reduce mortality from sepsis, although the underlying mechanisms have not been clearly defined in vivo. We hypothesized that P2Y12 inhibitors may improve survival from sepsis by suppressing systemic inflammation and its prothrombotic effects. We therefore determined whether clopidogrel and the novel, more potent P2Y12 inhibitor, ticagrelor, modify these responses in an experimental human model. Approach and Results - We randomized 30 healthy volunteers to ticagrelor (n=10), clopidogrel (n=10) or no antiplatelet medication (controls; n=10). We examined the effect of P2Y12 inhibition on systemic inflammation, which was induced by intravenous injection of E.coli endotoxin. Both P2Y12 inhibitors significantly reduced platelet-monocyte aggregate formation and peak levels of major pro-inflammatory cytokines, including TNFα, IL-6 and CCL2. In contrast to clopidogrel, ticagrelor also significantly reduced peak levels of IL-8 and G-CSF and increased peak levels of the anti-inflammatory cytokine IL-10. In addition, ticagrelor altered leukocyte trafficking. Both P2Y12 inhibitors suppressed D-dimer generation and scanning electron microscopy revealed that ticagrelor also suppressed prothrombotic changes in fibrin clot ultrastructure. Conclusions – Potent inhibition of multiple inflammatory and prothrombotic mechanisms by P2Y12 inhibitors demonstrates critical importance of platelets as central orchestrators of systemic inflammation induced by bacterial endotoxin. This provides novel mechanistic insight into the lower mortality associated with P2Y12 inhibitors in patients with sepsis in clinical studies.

Item Type: Thesis (PhD)
Academic Units: The University of Sheffield > Faculty of Medicine, Dentistry and Health (Sheffield) > Medicine (Sheffield)
Identification Number/EthosID: uk.bl.ethos.686486
Depositing User: Dr Mark Thomas
Date Deposited: 26 May 2016 14:30
Last Modified: 23 Dec 2019 11:04
URI: http://etheses.whiterose.ac.uk/id/eprint/13020

You do not need to contact us to get a copy of this thesis. Please use the 'Download' link(s) above to get a copy.
You can contact us about this thesis. If you need to make a general enquiry, please see the Contact us page.

Actions (repository staff only: login required)